We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Feb 21
Under the agreement, CureVac will initially supply 50 million doses of multi-variant Covid-19 vaccines to the UK with…
08 Feb 21
Breyanzi demonstrated a 73% overall response rate and 54% complete response (CR) rate in TRANSCEND NHL 001 trial
05 Feb 21
The drugmaker claims that Forxiga is the first SGLT2 inhibitor approved in China to treat heart failure with…
04 Feb 21
GSK will assist in the production of up to 100 million doses of CureVac’s first-generation Covid-19 vaccine CVnCoV…
04 Feb 21
The vaccine demonstrated 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase 3…
03 Feb 21
WuXi STA will acquire the operations and assets of Couvet site, including the plant and equipment, along with…
02 Feb 21
Horizon will benefit from Viela Bio’s Uplizna, and additional investigational drug candidates VIB4920, VIB7734, and VIB1116
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
02 Feb 21
Plegridy intramuscular injection offers a treatment option with reduced injection site reactions for individuals with relapsing multiple sclerosis…
01 Feb 21
The vaccine showed 72% effectiveness in the US and an overall 66% effectiveness in preventing Covid-19 after 28…
29 Jan 21
Lilly will be responsible for global development and regulatory activities for AK1780 in the future